SER — SERINA THERAPEUTICS INC
As of Q2 2026, 7 SEC-registered investment managers reported holding SER (SERINA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $153.51K across 79.13K shares. That is -37.6% by share count (-47.73K shares) versus the previous quarter, while reported value moved -37.6%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions, 2 added to existing stakes, 2 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
SER is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 180.01K | $344.37K | 0.00% | Hold |
| Geode Capital Management history | Q2 2026 | 51.01K | $98.95K | 0.00% | Reduce |
| Citadel Advisors history | Q1 2025 | 13.18K | $74.75K | 0.00% | New |
| Millennium Management history | Q1 2025 | 10.72K | $60.79K | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 20.77K | $40.30K | 0.00% | New |
| Citigroup Inc history | Q3 2025 | 2.32K | $12.45K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 3.61K | $7.01K | 0.00% | Hold |
| BlackRock Inc history | Q2 2026 | 2.38K | $4.61K | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 1.35K | $2.61K | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 14 | $28 | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q1 2025 | 1 | $8 | 0.00% | New |
| Bank of America Corp history | Q4 2025 | 3 | $6 | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 1 | $2 | 0.00% | New |
New Positions (Q2 2026)
- Northern Trust Corp 20.77K sh · $40.30K
- JPMorgan Chase & Co 1 sh · $2
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 13 funds)
| Fund | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | — | 22.75K | 24.03K | 26.20K | 29.21K | 28.88K | 29.61K | 30.41K | 64.97K | 51.01K |
| Northern Trust Corp | — | — | 14.79K | 14.79K | 17.01K | 16.50K | 14.54K | 14.08K | — | 20.77K |
| Wells Fargo & Co | 58 | 2 | 2 | 2 | 2 | 2 | 2 | 3.60K | 3.61K | 3.61K |
| BlackRock Inc | — | — | 3.57K | 3.57K | 3.07K | 11.77K | 13.12K | 17.25K | 58.26K | 2.38K |
| UBS Group AG | 5 | 1.03K | 1 | 3.81K | 747 | 1 | 3.47K | 433 | 5 | 1.35K |
| Morgan Stanley | 10 | 4 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 14 |
| JPMorgan Chase & Co | 1 | 11 | 13 | 13 | 12 | 9 | 10 | — | — | 1 |
| Bank of America Corp | — | 31 | 24 | 24 | 26 | 29 | 215 | 3 | — | — |
| Citigroup Inc | 656 | — | — | — | — | — | 2.32K | — | — | — |
| Vanguard Group | 19.95K | 22.13K | 44.50K | 62.07K | 65.33K | 150.62K | 180.01K | 180.01K | — | — |
| Citadel Advisors | — | — | — | — | 13.18K | — | — | — | — | — |
| Fidelity Management & Research (FMR) | — | — | — | — | 1 | — | — | — | — | — |
| Millennium Management | — | 21.67K | 19.26K | 14.55K | 10.72K | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details